Efficacy and Safety of ReLEx Smile for Laser Correction of Myopia
Launched by UNIVERSITY OF AARHUS · Nov 29, 2011
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
Quality control study of patients treated with ReLEx smile for myopia at the Department of Ophthalmology, Aarhus University Hospital.
The patients will be followed with standard clinical techniques (slit-lamp examination, refraction, topography) during their normal follow-up up to 12 months after treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Indication for keratorefractive correction of myopia
- • Patient consent to undergo keratorefractive correction of myopia
- Exclusion Criteria:
- • Pregnant or lactating women
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus C, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials